{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:16:48Z","timestamp":1753892208723,"version":"3.41.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Dystrophic cardiomyopathy arises from mutations in the dystrophin gene. Dystrophin forms part of the dystrophin glycoprotein complex and is postulated to act as a membrane stabilizer, protecting the sarcolemma from contraction-induced damage. Duchenne muscular dystrophy (DMD) is the most severe dystrophinopathy, caused by a total absence of dystrophin. Patients with DMD present with progressive skeletal muscle weakness and, because of treatment advances, a cardiac component of the disease (i.e., dystrophic cardiomyopathy) has been unmasked later in disease progression. The role that myofilaments play in dystrophic cardiomyopathy is largely unknown and, as such, this study aimed to address cardiac myofilament function in a mouse model of muscular dystrophy. To assess the effects of DMD on myofilament function, isolated permeabilized cardiomyocytes of wild-type (WT) littermates and Dmd<jats:sup>mdx-4cv<\/jats:sup> mice were attached between a force transducer and motor and subjected to contractile assays. Maximal tension and rates of force development (indexed by the rate constant, <jats:italic>k<\/jats:italic><jats:sub><jats:italic>tr<\/jats:italic><\/jats:sub>) were similar between WT and Dmd<jats:sup>mdx-4cv<\/jats:sup> cardiac myocyte preparations. Interestingly, Dmd<jats:sup>mdx-4cv<\/jats:sup> cardiac myocytes exhibited greater sarcomere length dependence of peak power output compared to WT myocyte preparations. These results suggest dystrophin mitigates length dependence of activation and, in the absence of dystrophin, augmented sarcomere length dependence of myocyte contractility may accelerate ventricular myocyte contraction-induced damage and contribute to dystrophic cardiomyopathy. Next, we assessed if mavacamten, a small molecule modulator of thick filament activation, would mitigate contractile properties observed in Dmd<jats:sup>mdx-4cv<\/jats:sup> permeabilized cardiac myocyte preparations. Mavacamten decreased maximal tension and <jats:italic>k<\/jats:italic><jats:sub><jats:italic>tr<\/jats:italic><\/jats:sub> in both WT and Dmd<jats:sup>mdx-4cv<\/jats:sup> cardiac myocytes, while also normalizing the length dependence of peak power between WT and Dmd<jats:sup>mdx-4cv<\/jats:sup> cardiac myocyte preparations. These results highlight potential benefits of mavacamten (i.e., reduced contractility while maintaining exquisite sarcomere length dependence of power output) as a treatment for dystrophic cardiomyopathy associated with DMD.<\/jats:p>","DOI":"10.3389\/fphys.2023.1207658","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T05:11:20Z","timestamp":1686287480000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dystrophic cardiomyopathy: role of the cardiac myofilaments"],"prefix":"10.3389","volume":"14","author":[{"given":"Thomas G.","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurin M.","family":"Hanft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maike","family":"Krenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy L.","family":"Domeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry S.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.yjmcc.2017.12.008","article-title":"Altered myofilament structure and function in dogs with Duchenne muscular dystrophy cardiomyopathy","volume":"114","author":"Ait Mou","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2174\/1874192401004010265","article-title":"Experimental models of duchenne muscular dystrophy: Relationship with cardiovascular disease","volume":"4","author":"Ameen","year":"2010","journal-title":"Open Cardiovasc Med. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1111\/bph.15271","article-title":"Effects of mavacamten on Ca(2+) sensitivity of contraction as sarcomere length varied in human myocardium","volume":"177","author":"Awinda","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"H881","DOI":"10.1152\/ajpheart.00345.2020","article-title":"Mavacamten decreases maximal force and Ca(2+) sensitivity in the N47K-myosin regulatory light chain mouse model of hypertrophic cardiomyopathy","volume":"320","author":"Awinda","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1750-3639.1996.tb00781.x","article-title":"Utrophin: A structural and functional comparison to dystrophin","volume":"6","author":"Blake","year":"1996","journal-title":"Brain Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e006340","DOI":"10.1161\/JAHA.117.006340","article-title":"Predictors of death in adults with duchenne muscular dystrophy-associated cardiomyopathy","volume":"6","author":"Cheeran","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1096\/fj.01-0030fje","article-title":"Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury","volume":"15","author":"Danialou","year":"2001","journal-title":"Faseb J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1203\/00006450-199207000-00025","article-title":"The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy","volume":"32","author":"Danko","year":"1992","journal-title":"Pediatr. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/s0960-8966(02)00140-2","article-title":"Survival in duchenne muscular dystrophy: Improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e202012770","DOI":"10.1085\/jgp.202012770","article-title":"Cardiac MyBP-C phosphorylation regulates the Frank-Starling relationship in murine hearts","volume":"153","author":"Hanft","year":"2021","journal-title":"J. Gen. Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1113\/jphysiol.2010.190504","article-title":"Length dependence of force generation exhibit similarities between rat cardiac myocytes and skeletal muscle fibres","volume":"588","author":"Hanft","year":"2010","journal-title":"J. Physiology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13395-018-0177-7","article-title":"Muscle membrane integrity in duchenne muscular dystrophy: Recent advances in copolymer-based muscle membrane stabilizers","volume":"8","author":"Houang","year":"2018","journal-title":"Skelet. Muscle"},{"key":"B14","doi-asserted-by":"publisher","first-page":"H2373","DOI":"10.1152\/ajpheart.00448.2005","article-title":"Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice","volume":"289","author":"Janssen","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.yjmcc.2018.10.008","article-title":"Voluntary exercise improves muscle function and does not exacerbate muscle and heart pathology in aged Duchenne muscular dystrophy mice","volume":"125","author":"Kogelman","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"Cd003725","DOI":"10.1002\/14651858.CD003725.pub4","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","volume":"2016","author":"Matthews","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-g","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int. J. Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e72147","DOI":"10.1371\/journal.pone.0072147","article-title":"Revertant fibers in the mdx murine model of duchenne muscular dystrophy: An age- and muscle-related reappraisal","volume":"8","author":"Pigozzo","year":"2013","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.nmd.2004.04.007","article-title":"Evolution of the mdx mouse cardiomyopathy: Physiological and morphological findings","volume":"14","author":"Quinlan","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0022-510x(96)00167-0","article-title":"Contractile properties of myocardium are altered in dystrophin-deficient mdx mice","volume":"142","author":"Sapp","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"H1112","DOI":"10.1152\/ajpheart.00325.2020","article-title":"Mavacamten preserves length-dependent contractility and improves diastolic function in human engineered heart tissue","volume":"320","author":"Sewanan","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11897-020-00456-0","article-title":"Duchenne muscular dystrophy: The heart of the matter","volume":"17","author":"Shih","year":"2020","journal-title":"Curr. Heart Fail Rep."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1002\/cphy.cp020107","volume-title":"Modulation of cardiac myofilament activity by protein phosphorylation","author":"Solaro","year":"2002"},{"key":"B24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/01.res.74.3.542","article-title":"Beta-adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats","volume":"74","author":"Strang","year":"1994","journal-title":"Circulation Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/cvr\/cvs161","article-title":"Bradykinin restores left ventricular function, sarcomeric protein phosphorylation, and e\/nNOS levels in dogs with Duchenne muscular dystrophy cardiomyopathy","volume":"95","author":"Su","year":"2012","journal-title":"Cardiovasc Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1152\/japplphysiol.00253.2010","article-title":"Lengthening-contractions in isolated myocardium impact force development and worsen cardiac contractile function in the mdx mouse model of muscular dystrophy","volume":"110","author":"Xu","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41536-018-0045-4","article-title":"Humanizing the mdx mouse model of DMD: The long and the short of it","volume":"3","author":"Yucel","year":"2018","journal-title":"NPJ Regen. Med."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1207658\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T05:11:23Z","timestamp":1686287483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1207658\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":27,"alternative-id":["10.3389\/fphys.2023.1207658"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2023.1207658","relation":{},"ISSN":["1664-042X"],"issn-type":[{"type":"electronic","value":"1664-042X"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"article-number":"1207658"}}